Baos Sarah, Sheehan Karen, Culliford Lucy, Pike Katie, Ellis Lucy, Parry Andrew J, Stoica Serban, Ghorbel Mohamed T, Caputo Massimo, Rogers Chris A
Clinical Trials and Evaluation Unit, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom.
JMIR Res Protoc. 2015 May 25;4(2):e59. doi: 10.2196/resprot.4338.
During open heart surgery, patients are connected to a heart-lung bypass machine that pumps blood around the body ("perfusion") while the heart is stopped. Typically the blood is cooled during this procedure ("hypothermia") and warmed to normal body temperature once the operation has been completed. The main rationale for "whole body cooling" is to protect organs such as the brain, kidneys, lungs, and heart from injury during bypass by reducing the body's metabolic rate and decreasing oxygen consumption. However, hypothermic perfusion also has disadvantages that can contribute toward an extended postoperative hospital stay. Research in adults and small randomized controlled trials in children suggest some benefits to keeping the blood at normal body temperature throughout surgery ("normothermia"). However, the two techniques have not been extensively compared in children.
The Thermic-2 study will test the hypothesis that the whole body inflammatory response to the nonphysiological bypass and its detrimental effects on different organ functions may be attenuated by maintaining the body at 35°C-37°C (normothermic) rather than 28°C (hypothermic) during pediatric complex open heart surgery.
This is a single-center, randomized controlled trial comparing the effectiveness and acceptability of normothermic versus hypothermic bypass in 141 children with congenital heart disease undergoing open heart surgery. Children having scheduled surgery to repair a heart defect not requiring deep hypothermic circulatory arrest represent the target study population. The co-primary clinical outcomes are duration of inotropic support, intubation time, and postoperative hospital stay. Secondary outcomes are in-hospital mortality and morbidity, blood loss and transfusion requirements, pre- and post-operative echocardiographic findings, routine blood gas and blood test results, renal function, cerebral function, regional oxygen saturation of blood in the cerebral cortex, assessment of genomic expression changes in cardiac tissue biopsies, and neuropsychological development.
A total of 141 patients have been successfully randomized over 2 years and 10 months and are now being followed-up for 1 year. Results will be published in 2015.
We believe this to be the first large pragmatic study comparing clinical outcomes during normothermic versus hypothermic bypass in complex open heart surgery in children. It is expected that this work will provide important information to improve strategies of cardiopulmonary bypass perfusion and therefore decrease the inevitable organ damage that occurs during nonphysiological body perfusion.
ISRCTN Registry: ISRCTN93129502, http://www.isrctn.com/ISRCTN93129502 (Archived by WebCitation at http://www.webcitation.org/6Yf5VSyyG).
在心脏直视手术中,患者会连接到体外循环机,在心脏停跳期间,该机器会将血液泵送到全身(“灌注”)。通常在此过程中血液会被冷却(“低温”),手术完成后再升温至正常体温。“全身冷却”的主要原理是通过降低身体的代谢率和减少氧气消耗,在体外循环期间保护大脑、肾脏、肺和心脏等器官免受损伤。然而,低温灌注也有一些缺点,可能会导致术后住院时间延长。针对成人的研究以及针对儿童的小型随机对照试验表明,在整个手术过程中将血液保持在正常体温(“常温”)有一些益处。然而,这两种技术在儿童中尚未得到广泛比较。
Thermic - 2研究将检验以下假设:在小儿复杂心脏直视手术中,将体温维持在35°C - 37°C(常温)而非28°C(低温),可能会减轻对非生理性体外循环的全身炎症反应及其对不同器官功能的有害影响。
这是一项单中心随机对照试验,比较141例接受心脏直视手术的先天性心脏病儿童进行常温与低温体外循环的有效性和可接受性。计划进行心脏缺陷修复手术且不需要深度低温循环停搏的儿童为目标研究人群。共同主要临床结局是血管活性药物支持时间、插管时间和术后住院时间。次要结局包括院内死亡率和发病率、失血量和输血需求、术前和术后超声心动图检查结果、常规血气和血液检查结果、肾功能、脑功能、大脑皮层血液区域氧饱和度、心脏组织活检中基因组表达变化的评估以及神经心理发育。
在2年10个月的时间里,共有141例患者成功随机分组,目前正在进行1年的随访。结果将于2015年发表。
我们认为这是第一项比较小儿复杂心脏直视手术中常温与低温体外循环临床结局的大型实用性研究。预计这项工作将提供重要信息,以改进体外循环灌注策略,从而减少非生理性身体灌注期间不可避免的器官损伤。
ISRCTN注册库:ISRCTN93129502,http://www.isrctn.com/ISRCTN93129502(由WebCitation存档于http://www.webcitation.org/6Yf5VSyyG)。